Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Jan 10;40(6):841–853. doi: 10.1016/j.vaccine.2021.12.059

Factors associated with COVID-19 vaccination intentions among adults in the deep South

Casey L Daniel a,b,, Jacob Williams a, Rachel Legg a, Chelsea McGowen b, Jesse Stutzman a
PMCID: PMC8744449  PMID: 35034834

Abstract

The recent approval of several COVID-19 vaccines signals progress toward controlling the pandemic. Although social distancing and masking have been effective, vaccines are an important additional measure of protection to reduce COVID-19 spread. Adequate uptake is essential to reach herd immunity, estimated to be approximately 67%. However, vaccine hesitancy, the fast-tracked nature of the COVID-19 vaccines, and misinformation circulating through various forms of media have contributed to lower vaccination intention than desired. The current research study developed an online survey conducted via Facebook to explore the attitudes and perceptions of adult Alabama residents about COVID-19 and the COVID-19 vaccines. Of the 3,781 respondents, only 44.3% reported intent to receive a vaccine, with a large proportion reporting they were unsure (28.1%). Lack of intention to vaccinate was associated with low educational attainment, low COVID-19 knowledge levels, low income, and African American race. The current survey also explored participants’ influenza vaccine behavior as this information can also be used to inform successful COVID-19 vaccine distribution. Of the respondents, 56% report receiving the yearly influenza vaccine and the majority receive it at a pharmacy or healthcare provider office. This informs likely successful locations for COVID-19 vaccine distribution. Appropriate education targeted to populations most likely to refuse COVID-19 vaccination is essential to promote uptake. The information collected from the current study should be utilized to inform effective and efficient vaccine distribution strategies.

Keywords: Coronavirus, COVID-19, Vaccination, Vaccine hesitancy

1. Introduction

SARS-CoV-2 is a novel coronavirus, a respiratory virus first identified in Wuhan, China in December 2019, and the cause of COVID-19 [1]. The first case in the United States (US) was confirmed on January 20, 2020 [2]. The U.S. has since sustained almost 30 million cases and over 500,000 deaths, with over 500,000 cases and over 10,000 deaths in Alabama, alone [3], [4]. These numbers continue to rise, indicating the ongoing presence of COVID-19 [3], [4].

COVID-19 is spread primarily through respiratory droplets by individuals nearby;[5] however, evidence shows the virus can also spread via airborne transmission as far as 10 m [6]. Current estimates place the mortality rate for those with symptomatic infections at between 2.3% and 7.2%, with acute respiratory distress syndrome (ARDS) as the leading cause of death [7]. This is roughly 10 times higher than the seasonal flu [8]. Unlike the seasonal flu, the COVID-19 virus appears to cause long term disability as well. Sometimes referred to as “Post-COVID Syndrome” (PCS), survivors may experience fatigue, body aches, shortness of breath, headache, hair loss, rash, and trouble sleeping, with some experiencing severe damage to the cardiovascular and respiratory systems [9], [10]. Despite extensive, ongoing research, much remains unknown about COVID-19.

Preventive measures such as widespread masking and social distancing have demonstrated effectiveness in slowing but not halting the spread of COVID-19. Vaccination is a necessary intervention to slow the pandemic [11], [12]. Mass vaccination, even for those who have been infected, is the key to safely reaching herd immunity. Approximately 67% of the population needs to be vaccinated to achieve herd immunity for COVID-19 [13]. Achieving this milestone in the United States will be difficult due to challenges associated with vaccination. These challenges include structural barriers and costs associated with the vaccine such as transportation, childcare, and administrative costs. While significant progress has been made in eliminating these barriers, vaccination still requires a personal decision on the part of the individual to accept vaccination.

Vaccine hesitancy, the unwillingness to accept a recommended vaccine in a timely fashion, is well-documented barrier to vaccination in the US [14], [15], [16]. Reasons for vaccine hesitancy include concerns about vaccine safety, including concern over potentially harmful ingredients, belief that healthy lifestyle and diet is sufficient to prevent disease, low perceived risk of disease, preference for natural immunity, mistrust of pharmaceutical companies, the government, and mainstream media, concerns of “overloading” the immune system, religious beliefs, limited belief in vaccine efficacy, and fear of injections [17], [18]. Due to the rapid development and approval of the COVID-19 vaccines, concerns regarding the vaccine’s safety profile may be amplified. Previous research has shown influenza vaccine uptake is positively influenced by past uptake, perceived benefits, social norms, and perceived social responsibility [18]. Currently, only 14% of the U.S. population is fully vaccinated while 25.7% have received at least one dose [19]. Among Alabama adults, 12.0% are fully vaccinated while 20.8% have received at least one dose [19], [20]. Vaccine acceptance increases with increasing income and education level and those of African American descent express greater hesitancy compared with Whites [21]. These trends hold true even among healthcare workers [21].

The purpose of the current study was to determine factors associated with COVID-19 vaccine intentions in a population of adult Alabama residents, in order to inform the development of targeted behavioral and clinical interventions to reduce hesitancy and increase uptake.

2. Methods

2.1. Survey development

An electronic survey was developed using Research Electronic Data Capture (REDCap) software to identify Alabama residents’ knowledge, attitudes, and perceptions regarding COVID-19 and the COVID-19 vaccines, as well as intention to receive a vaccine [22]. The survey was available for 17 days in November 2020 and took approximately 15 min to complete. Before initiating the survey, individuals were required to acknowledge receipt of, and agreement to, informed consent. People were eligible to participate if they were current residents of Alabama, 18 or older, English-speaking, and had a Facebook account. Participants were recruited using demonstrated effective methods through Facebook advertising strategies [23], [24]. The study was approved by the University of South Alabama Institutional Review Board (PROTOCOL: 20–402).

2.2. Measures

The primary outcome of interest was intent to receive COVID-19 vaccination when presented with the opportunity. Participants were given the response options: “Yes,” “No,” or, “Don’t know/Not sure,” to the question, “When an FDA-approved vaccine for COVID-19 becomes available, will you get it?” Explanatory measures included demographics (age, sex, race, educational attainment, marital status, income, employment, health insurance, healthcare engagement, general attitudes regarding vaccine acceptability, rurality), influenza vaccine behaviors/attitudes (history of influenza vaccination, influenza vaccine intentions of self as well as dependents, motivators/barriers to vaccine receipt, typical location of vaccine receipt, effect of COVID-19 pandemic on influenza vaccine intentions), COVID-19 knowledge (assessed by 11 agree/disagree statements), COVID-19 perceptions/beliefs (assessed by 15, 5-point Likert scale questions with responses ranging from ‘Strongly Disagree’ to ‘Strongly Agree’), preventive behaviors (assessed by 8, 5-point Likert scale questions referring to participation in each behavior due to COVID-19 in the two weeks prior, with responses ranging from ‘Very Frequently’ to ‘Never’), personal COVID-19 impact (history of positive tests, subjective likelihood of contracting COVID-19 in the next 6 months), and COVID-19 vaccine influences (location of vaccine receipt and motivators of self). Measures included on the final survey consisted of original questions and measures adapted from previous studies [18]. Due to small sample sizes, the race categories, “American Indian or Alaska Native,” “Asian,” “More than one race,” and, “Other,” were combined to form the “Other” category used for analysis. Similarly, “Some school” and “High school graduate” were combined in the education attainment category, “Unemployed” and “Disabled” were combined in the employment status category, “Very poor” and “Poor” were combined in the health rating category, and “Very liberal” and “Liberal” were combined, as were “Very conservative” and “Conservative,” in the political views category. Rurality was determined by Rural-Urban Commuting Area designations of participants’ provided zip code (“urban” designated by codes 1–3 and “rural” by codes 4–10) [25]. A summary score was created for the 11 knowledge questions by calculating the sum of correct responses. Sums for participants with unanswered questions were adjusted to 11 based on percent correct (excluding participants with>3 omitted responses). A preventive practices summary score was also created to assess the frequency by which participants engaged in preventive behaviors such as hand washing, wearing a face mask in public or small gatherings, avoidance of grocery shopping or dining in-person, wearing gloves, frequent disinfection of surfaces, and avoiding gatherings of 10 or more people. Responses were categorized numerically (1 = “Very frequently” and 5 = “Very Rarely”) and the mean score recorded for the 8 assessed practices. Means were then grouped by quintile to create 5 even bins for analysis. At survey completion, participants had the option to be entered into a drawing for one of 200 Visa gift cards each worth $25. Survey responses were not linked to any identifying information.

2.3. Recruitment strategy and advertisement design

Facebook’s advertising platform was used to distribute the survey and recruit participants based on prior studies’ demonstrated success and the majority of Alabama’s population older than 18 years of age being registered on Facebook (61.2%-71.4%) [23], [24], [26]. Facebook runs advertisements across multiple channels and applications, including Facebook and Instagram feeds, Facebook Messenger, user stories, and on apps within the Facebook Audience Network. To mitigate the overrepresentation of females and individuals of European descent common to survey research, the current advertising strategy oversampled men and minorities [27].

A total of three advertisements were designed, composed of: a brief overview of the survey, a single image, a headline reading, “Alabama COVID-19 Survey,” and a website URL that would take the participant to the survey (Fig. 1 ). Images varied by advertisement, depending on the targeted audience. Images were pilot tested on local individuals who met the inclusion criteria (n = 33).

Fig. 1.

Fig. 1

Facebook Survey Advertisements. Top row, from left to right: initial forms of Ads 1, 2, and 3. Bottom row, from left to right: final forms of Ads 1, 2, and 3 (Ad 1 format unchanged).

2.4. Advertising campaign

The advertisements were live for a total of 17 days. Ad 1 ran unaltered for the full 17 days, amassing 2,633 clicks on a budget of $1,440.39. Ad 2, targeting males, also ran for the full 17 days, but the image was changed on the third day to boost advertisement interaction. Ad 2 amassed 2,607 clicks on a budget of $1,379.11. Ad 3 was created on the fifth day to appeal more to ethnic minorities who were not responding well to Ads 1 and.

2.5. It ran for 12 days, amassing 1,086 clicks on a budget of $955.56

Throughout the advertising campaign, comments from Facebook users on the advertisements were hidden to reduce bias due to COVID-19′s polarizing nature. Participants were encouraged to Facebook Message the ad’s home page if communication with the study team was needed.

2.6. Statistical analysis

There were 3,952 survey respondents out of 6,326 advertisement link clicks (62.5% survey completion rate). Of these, 3,781 were included in the study (41 did not meet the Alabama residency requirement and 130 were excluded for not responding to the primary outcome of interest. Bivariate measures were assessed via χ2 analyses to compare vaccination intent to respondents’ demographic characteristics and responses to key survey questions. Multinomial logistic regression analyses were performed to assess determinants of vaccine hesitancy using the response of “Don’t know/Not sure” for COVID-19 vaccination intent as the referent group. Both unadjusted and adjusted Odds Ratios (ORs) with 95% Wald confidence intervals (CI) were obtained and reported. Adjusted ORs (AORs) were adjusted for demographic information via complete case analysis. There were few missing data for most variables, with the exception of income (16% missing), age (9%) and political views (10%). AORs were not adjusted for income due to the high number of missing responses and the tendency for those responses to be missing not at random. Multicollinearity was assessed using a variance inflation factor (VIF) threshold of 2.5. Statistical significance was determined at p < 0.05; however, to mitigate the potentially increased risk of Type I error due to multiple testing, results were interpreted at the stricter level of p < 0.001. All statistics were performed via SAS Studio 3.1 (Cary, NC, USA).

3. Results

Of the 3,781 eligible respondents, the majority self-identified as female (65.3%) and White (88.6%). Black/African American respondents made up 6.0% of responses. Mean age was 54.5 years old (standard deviation: 15.4). The majority of participants (88.7%) had completed at least some college. Most respondents reported full-time employment (45.4%) or retirement (32.3%) and an annual household income of at least $50,000 before taxes (67%). Nearly 95% of respondents reported having health insurance. Over half (67.5%) of participants had health care visits at least twice a year, and 87.7% reported having a primary care provider for most of their healthcare. Over half (60.3%) reported their health as “good” (Table 1 ).

Table 1.

Participant characteristics.

Variable (N = 3781) N (%)
Age

18–34 445 (13.0)
35–49 772 (22.5)
50–64 1167 (34.0)
65+ 1049 (30.6)
Rural vs Urban zip code
Urban 2944 (78.6)
Rural 803 (21.4)
Gender
Female 2470 (66.1)
Male 1267 (33.9)
Race
White 3302 (90.8)
Black or African American 198 (5.4)
Other 136 (3.7)
Education
Graduate degree 947 (25.2)
College graduate 1328 (35.3)
Some college 1060 (28.2)
Some school or high school graduate 422 (11.2)
Do you currently have health insurance?
Yes 3517 (94.4)
No 210 (5.6)
Do you currently have a primary health care provider or clinic where you go for most of your healthcare?
Yes 3272 (87.7)
No 460 (12.3)
How frequently do you see a healthcare provider?
4 + times per year 749 (20.3)
2–3 times per year 1745 (47.2)
1 time per year 648 (17.5)
< 1 time per year 554 (15.0)
How would you rate your general health?
Excellent 704 (18.7)
Good 2266 (60.3)
Fair 686 (18.2)
Poor 103 (2.7)
What is your marital status?
Married/living together 2592 (70.1)
Never married 376 (10.2)
Divorced or separated 493 (13.3)
Widowed 236 (6.4)
Annual household income
Less than $20,000 262 (8.2)
$20,000-$34,999 384 (12.1)
$35,000-$49,000 402 (12.6)
$50,000-$74,999 683 (21.4)
$75,000-$99,000 584 (18.3)
$100,000 or more 870 (27.3)
Employment status
Full-time employed/homemaker 1887 (51.3)
Part-time employed 267 (7.3)
Unemployed or disabled 293 (8.0)
Student 55 (1.5)
Retired 1176 (32.0)
How would you describe your political views?
Liberal 781 (23.0)
Moderate 925 (27.2)
Conservative 1694 (49.8)
Do you usually get a flu vaccine?
Yes 2326 (61.9)
No 1430 (38.1)
Have you had or do you plan to get the flu vaccine this year?
Yes 2499 (66.4)
No 1065 (28.3)
Don't know/Not sure 198 (5.3)
How has the COVID-19 pandemic affected your likelihood of getting the flu vaccine this year?
Made me more likely to get it 1021 (27.6)
Has not affected my likelihood 2432 (65.6)
Made me less likely to get it 252 (6.8)
Have you ever tested positive for COVID-19?
No 3485 (92.8)
Yes 272 (7.2)
How likely do you think it is that you could get COVID-19 in the next 6 months?
Very likely 339 (9.2)
Somewhat likely 1690 (45.9)
Not very likely 1010 (27.4)
Very unlikely 469 (12.7)
I have already had COVID-19 172 (4.7)
When an FDA-approved vaccine for COVID-19 becomes available, will you get it?
Yes 1676 (44.3)
No 1044 (27.6)
Don’t know/not sure 1061 (28.1)

The majority of respondents reported they receive an influenza vaccine annually (61.8%) and cited prevention, recommendation by a healthcare provider, belief in the importance of vaccines, and preventing severe disease as the most common reasons for vaccination. Among participants who did not get an annual influenza vaccine, the most common reasons were: concerns about efficacy, side effects, and ingredients, as well as not believing they are at risk for influenza (Table 2 ). 66.4% of respondents reported they had already received an influenza vaccine or planned to be vaccinated this season. Additionally, 27.6% indicated that the COVID-19 pandemic made them more likely to get the influenza vaccine this year (Table 1). Participants were most likely to receive an influenza vaccine from their healthcare provider or at a pharmacy and indicated similar preferences for COVID-19 vaccination location (Table 2).

Table 2.

Participant attitudes towards the flu vaccine and location preferences for flu and COVID-19 vaccination.

Variable (N = 3781) N (%)
Why do you get a flu shot?
Required for work/school 251 (10.8)
To prevent flu 1797 (77.3)
Healthcare provider recommends it 892 (38.3)
Family/friends recommend it 237 (10.2)
Incentives/gift cards 180 (7.7)
Vaccines are important 1046 (45.0)
If you get the flu, it won’t be as bad if you have had a flu shot 983 (42.3)
I don’t want to risk getting others sick 779 (33.5)
I am immunosuppressed 146 (6.3)
I am considered at risk 392 (16.9)
Other 63 (2.7)
Prefer not to answer 4 (0.2)
Why do you not get a flu shot?
I do not support vaccinations of any kind 85 (5.9)
I do not think flu shots are effective 524 (36.6)
It has made me feel bad in the past 308 (21.5)
Cost 39 (2.7)
Health insurance does not cover it 6 (0.4)
No convenient places for me to get it 14 (1.0)
No convenient times for me to get it 23 (1.6)
I am concerned I will get the flu from the vaccine 109 (7.6)
I don’t get the flu so I don’t need the vaccine 200 (14.0)
I have never gotten the flu vaccine 296 (20.7)
I don’t like needles/it hurts 64 (4.5)
I am concerned about side effects 237 (16.6)
I don’t think I will get very sick from the flu 179 (12.5)
Concerned about vaccine ingredients 243 (17.0)
Healthcare provider does not recommend it 17 (1.2)
Allergic to vaccine ingredients 81 (5.7)
I don’t think about it/I forget 170 (11.9)
Other 106 (7.4)
Prefer not to answer 32 (2.2)
Where are you most likely to get a flu shot?
Healthcare provider/regular clinic 1242 (41.7)
Urgent care 72 (2.4)
Health department 155 (5.2)
Chain pharmacy (Walgreen’s, CVS, etc.) 810 (27.2)
Independent/community pharmacy 172 (5.8)
Pharmacy within a store (Wal-Mart, Publix, etc.) 768 (25.8)
My job 464 (15.6)
None of the above 228 (7.7)
Other 22 (0.7)
Prefer not to answer 24 (0.8)
Where would you be most likely to get a COVID-19 vaccine, if it were available?
My healthcare provider/regular clinic 1974 (69.0)
Urgent care 334 (11.7)
Health Department 509 (17.8)
Chain pharmacy (such as Walgreen’s, CVS, etc.) 938 (32.8)
Independent or community pharmacy 338 (11.8)
Pharmacy within a store (such as Wal-Mart, Publix, Target, etc) 739 (25.8)
Drive-thru vaccine clinic 546 (19.1)
None of the above 30 (1.0)
Other 132 (4.6)
Prefer not to answer 79 (2.8)

Both younger (18–34) and older (65 + ) participants reported increased intention to vaccinate compared with those aged 35–49 and 50–64 (47.0% and 54.1% vs. 33.9% and 41.8%, respectively). Respondents living in rural areas were evenly split between the answer choices regarding COVID-19 vaccine intention and almost 10% more of those living in urban areas reported intention to vaccinate (46.3% vs. 37.4%). Race was a major factor and almost twice as many whites as African Americans reported intention to vaccinate (46.2% vs. 23.0%) and almost half (49.0%) of African American respondents were undecided. Among participants with post-graduate degrees, 60.7% reported intention to receive a COVID-19 vaccine vs. 45.6% of college graduates and 29.9% of those with a high school education or less. Almost half (49.0%) of participants without insurance reported not planning to receive a COVID-19 vaccine. (Table 3 )

Table 3.

Participant characteristics and survey frequencies according to intention to vaccinate.


Plan to receive COVID-19 vaccine (N = 3,781)
Yes (%) No (%) Don't know/Not sure (%) p-value
Age
18–34 209 (13.7) 126 (13.3) 110 (11.5) <0.0001
35–49 262 (17.2) 306 (32.3) 204 (21.3)
50–64 488 (32.0) 335 (35.3) 344 (35.9)
65+ 568 (37.2) 181 (19.1) 300 (31.3)
Rural vs Urban zip code
Urban 1362 (81.9) 758 (73.4) 824 (78.3) <0.0001
Rural 300 (18.1) 247 (26.6) 229 (21.7)
Gender
Female 1100 (33.9) 602 (41.4) 768 (26.6) <0.0001
Male 563 (66.1) 426 (58.6) 278 (73.4)
Race
White 1526 (92.9) 881 (90.4) 895 (87.8) <0.0001
Black or African American 47 (2.9) 54 (5.5) 97 (9.5)
Other 69 (4.2) 40 (4.1) 27 (2.6)
Education
Graduate degree 575 (34.4) 149 (14.4) 223 (21.2) <0.0001
College graduate 606 (36.3) 348 (33.7) 374 (35.5)
Some college 364 (21.8) 363 (35.1) 333 (31.6)
Some school or high school graduate 126 (7.5) 173 (16.7) 123 (11.7)
Do you currently have health insurance?
Yes 1615 (96.8) 907 (89.8) 995 (94.9) <0.0001
No 53 (3.2) 103 (10.2) 54 (5.1)
Do you currently have a primary health care provider or clinic where you go for most of your healthcare?
Yes 1505 (90.4) 837 (82.5) 930 (88.4)
No 160 (9.6) 178 (17.5) 122 (11.6)
How frequently do you see a healthcare provider?
4 + times per year 361 (21.8) 160 (15.9) 228 (21.9) <0.0001
2–3 times per year 840 (50.8) 371 (37.0) 534 (51.4)
1 time per year 274 (16.6) 204 (20.3) 170 (16.4)
< 1 time per year 178 (10.8) 269 (26.8) 107 (10.3)
How would you rate your general health?
Excellent 266 (16.0) 280 (27.0) 158 (15.0) <0.0001
Good 1038 (62.3) 589 (56.7) 639 (60.5)
Fair 319 (19.2) 146 (14.1) 221 (20.9)
Poor 42 (2.5) 23 (2.2) 38 (3.6)
What is your marital status?
Married/living together 1135 (68.4) 756 (75.3) 701 (67.9) 0.0005
Never married 193 (11.6) 76 (7.6) 107 (10.4)
Divorced or separated 215 (13.0) 124 (12.4) 154 (14.9)
Widowed 117 (7.0) 48 (4.8) 71 (6.9)
Annual household income
Less than $20,000 109 (7.5) 69 (8.1) 84 (9.7) 0.0103
$20,000-$34,999 149 (10.2) 106 (12.4) 129 (14.9)
$35,000-$49,000 176 (12.1) 112 (13.1) 114 (13.1)
$50,000-$74,999 308 (21.1) 192 (22.4) 183 (21.1)
$75,000-$99,000 282 (19.3) 158 (18.4) 144 (16.6)
$100,000 or more 436 (29.9) 220 (25.7) 214 (24.7)
Employment status
Full-time employed/homemaker 720 (43.4) 620 (62.2) 547 (53.5) <0.0001
Part-time employed 117 (7.0) 78 (7.8) 72 (7.0)
Unemployed or disabled 124 (7.5) 87 (8.7) 82 (8.0)
Student 41 (2.5) 7 (0.7) 7 (0.7)
Retired 658 (39.6) 204 (20.5) 314 (30.7)
How would you describe your political views?
Liberal 584 (36.8) 32 (3.5) 165 (18.1) <0.0001
Moderate 470 (29.6) 172 (19.1) 283 (31.0)
Conservative 532 (33.5) 698 (77.4) 464 (50.9)
Have you had or do you plan to get the flu vaccine this year?
Yes 1532 (91.8) 221 (21.3) 746 (70.6) <0.0001
No 76 (4.6) 772 (74.5) 217 (20.5)
Don't know/Not sure 61 (3.7) 43 (4.2) 94 (8.9)
How has the COVID-19 pandemic affected your likelihood of getting the flu vaccine this year?
Made me more likely to get it 700 (42.3) 42 (4.1) 279 (26.9) <0.0001
Has not affected my likelihood 930 (56.2) 789 (77.9) 713 (68.8)
Made me less likely to get it 25 (1.5) 182 (18) 45 (4.3)
Have you ever tested positive for COVID-19?
No 1568 (93.8) 948 (91.8) 969 (92.0) 0.0729
Yes 103 (6.2) 85 (8.2) 84 (8.0)
Frequency of engagement in preventative measures, composite score:
Very frequently 434 (25.9) 63 (6.0) 214 (20.2) <0.0001
Somewhat frequently 525 (31.3) 70 (6.7) 259 (24.4)
Occasionally 394 (23.5) 91 (8.7) 210 (19.8)
Rarely 258 (15.4) 233 (22.4) 256 (24.1)
Never 64 (3.8) 585 (56.1) 122 (11.5)
Knowledge Questions:
It can take 214 days for coronavirus symptoms to appear in an infected person.
Agree 1647 (98.9) 869 (89.0) 1021 (97.6) <0.0001
Disagree 19 (1.1) 107 (11.0) 25 (2.4)
Individuals should quarantine after exposure to someone positive for COVID-19.
Agree 1610 (96.8) 575 (58.0) 939 (90.2) <0.0001
Disagree 54 (3.2) 416 (42.0) 102 (9.8)
COVID-19 can live on surfaces, such as counters and doorknobs.
Agree 1514 (91.9) 646 (66.1) 895 (87.5) <0.0001
Disagree 134 (8.1) 332 (33.9) 128 (12.5)
COVID-19 can cause lasting health issues even after recovery from the illness.
Agree 1587 (96.9) 631 (67.3) 937 (93.0) <0.0001
Disagree 51 (3.1) 307 (32.7) 70 (7.0)
Wearing a face mask helps to prevent the spread of COVID-19.
Agree 1560 (94.3) 297 (29.6) 825 (81.4) <0.0001
Disagree 94 (5.7) 707 (70.4) 189 (18.6)
People infected with COVID-19 who do not have the symptoms cannot spread the virus.
Agree 170 (10.3) 264 (28.3) 109 (10.6) <0.0001
Disagree 1484 (89.7) 669 (71.7) 919 (89.4)
Most people with COVID-19 will have severe or critical symptoms.
Agree 105 (6.4) 60 (5.9) 95 (9.1) 0.0064
Disagree 1541 (93.6) 957 (94.1) 945 (90.9)
COVID-19 can spread through respiratory droplets of infected people.
Agree 1652 (99.3) 861 (87.4) 1033 (98.9) <0.0001
Disagree 11 (0.7) 124 (12.6) 11 (1.1)
Underlying medical conditions increase your risk for developing a severe case of COVID-19.
Agree 1646 (98.8) 891 (88.8) 1016 (97.0) <0.0001
Disagree 20 (1.2) 112 (11.2) 31 (3.0)
People with COVID-19 can infect others days before they start having symptoms.
Agree 1599 (97.7) 645 (68.4) 929 (92.7) <0.0001
Disagree 38 (2.3) 298 (31.6) 73 (7.3)
If you are wearing a mask it is not necessary to social distance.
Agree 77 (4.7) 338 (37.4) 109 (10.7) <0.0001
Disagree 1574 (95.3) 565 (62.6) 907 (89.3)
Knowledge composite score
11 1160 (69.5) 186 (19.1) 580 (56.2) <0.0001
>8–10 446 (26.7) 296 (30.5) 336 (32.6)
>6–8 49 (2.9) 229 (23.6) 79 (7.7)
0–6 14 (0.8) 261 (26.9) 37 (3.6)
Belief statements:
COVID-19 is deadlier than seasonal flu.
Strongly Agree 992 (59.3) 94 (9.1) 401 (38.0) <0.0001
Agree 409 (24.4) 108 (10.4) 254 (24.1)
Neutral 141 (8.4) 181 (17.5) 227 (21.5)
Disagree 106 (6.3) 328 (31.6) 131 (12.4)
Strongly Disagree 26 (1.6) 326 (31.4) 42 (4.0)
I am worried about spreading COVID-19 to others.
Strongly Agree 600 (35.9) 61 (5.9) 219 (20.8) <0.0001
Agree 669 (40.0) 127 (12.3) 367 (34.9)
Neutral 191 (11.4) 192 (18.6) 225 (21.4)
Disagree 155 (9.3) 336 (32.5) 181 (17.2)
Strongly Disagree 56 (3.4) 319 (30.8) 61 (5.8)
COVID-91 is a serious disease.
Strongly Agree 1216 (72.8) 139 (13.4) 564 (53.5) <0.0001
Agree 353 (21.1) 266 (25.7) 328 (31.1)
Neutral 56 (3.4) 254 (24.6) 102 (9.7)
Disagree 27 (1.6) 197 (19.1) 44 (4.2)
Strongly Disagree 18 (1.1) 178 (17.2) 17 (1.6)
People do not take COVID-19 seriously enough.
Strongly Agree 1033 (61.7) 137 (13.3) 453 (42.8) <0.0001
Agree 394 (23.6) 98 (9.5) 250 (23.6)
Neutral 117 (7.0) 208 (20.2) 180 (17.0)
Disagree 92 (5.5) 298 (29.0) 134 (12.7)
Strongly Disagree 37 (2.2) 288 (28.0) 41 (3.9)
I am worried about getting COVID-19.
Strongly Agree 513 (30.8) 65 (6.3) 201 (19.1) <0.0001
Agree 638 (38.2) 87 (8.4) 324 (30.8)
Neutral 305 (18.3) 146 (14.1) 251 (23.9)
Disagree 158 (9.5) 283 (27.4) 210 (20.0)
Strongly Disagree 54 (3.2) 452 (43.8) 66 (6.3)
COVID-19 is a political issue.
Strongly Agree 257 (15.5) 559 (54.4) 204 (19.4) <0.0001
Agree 327 (19.8) 242 (23.6) 237 (22.6)
Neutral 169 (10.2) 98 (9.5) 179 (17.0)
Disagree 258 (15.6) 63 (6.1) 165 (15.7)
Strongly Disagree 644 (38.9) 65 (6.3) 265 (25.2)

Unadjusted and adjusted ORs comparing “Yes” and “No” versus “Don’t know/Not sure” are summarized in Table 4 . Notable demographic factors influencing vaccine intention included education level and political views. Lower educational attainment was associated with an increased likelihood of “No” versus “Don’t know/Not sure” (high school education or less versus graduate school AOR: 2.02, 95% CI: 1.33–3.05), and a decreased likelihood of “Yes” (AOR: 0.39, 95% CI: 0.28–0.55). Moderate or conservative political views were also associated with an increased likelihood of “No” versus liberal views (moderate AOR: 3.30, 95% CI: 1.93–5.64; conservative AOR: 7.85, 95% CI: 4.64–13.29) and a decreased likelihood of “Yes” (moderate AOR: 0.48, 95% CI: 0.36–0.62; conservative AOR: 0.28, 95% CI: 0.21–0.37).

Table 4.

Variables associated with responses of “Yes” or “No” to intention to vaccinate.

Variable Unadjusted Analyses Adjusted Analysesa
Yes No Yes No
OR [95% CI] OR [95% CI] p-value AOR [95% CI] AOR [95% CI] p-value
Age
18–34 ref ref <0.0001 ref ref 0.0022
35–49 0.68 [0.5–0.91] 1.31 [0.96–1.79] 0.77 [0.55–1.08] 1.13 [0.77–1.67]
50–64 0.75 [0.57–0.98] 0.85 [0.63–1.14] 0.87 [0.63–1.20] 0.72 [0.49–1.07]
65+ 1 [0.76–1.31] 0.53 [0.38–0.72] 0.62 [0.41–0.93] 0.59 [0.35–0.97]
Rural vs Urban zip code
Urban ref ref <0.0001 ref ref 0.0461
Rural 0.79 [0.65–0.96] 1.3 [1.06–1.59] 0.86 [0.69–1.07] 1.21 [0.93–1.57]
Gender
Female ref ref <0.0001 ref ref <0.0001
Male 1.41 [1.19–1.68] 1.95 [1.62–2.35] 1.56 [1.27–1.92] 1.53 [1.19–1.96]
Race
White ref ref <0.0001 ref ref <0.0001
Black or African American 0.28 [0.2–0.41] 0.57 [0.4–0.8] 0.27 [0.18–0.40] 0.87 [0.55–1.37]
Otherb 1.5 [0.95–2.36] 1.51 [0.92–2.47] 1.31 [0.79–2.18] 1.28 [0.69–2.35]
Highest educational attainment
Graduate degree ref ref <0.0001 ref ref <0.0001
College graduate 0.63 [0.51–0.77] 1.39 [1.08–1.79] 0.69 [0.54–0.86] 1.20 [0.87–1.66]
Some college 0.42 [0.34–0.53] 1.63 [1.26–2.11] 0.45 [0.35–0.58] 1.51 [1.08–2.10]
High school graduate or less 0.4 [0.3–0.53] 2.11 [1.54–2.87] 0.39 [0.28–0.55] 2.02 [1.33–3.05]
Do you currently have health insurance?
Yes 0.6 [0.41–0.89] 2.09 [1.49–2.94] <0.0001 ref ref 0.9192
No ref ref 0.92 [0.57–1.50] 1.03 [0.65–1.61]
Do you currently have a primary health care provider or clinic where you go for most of your healthcare?
Yes ref ref <0.0001 ref ref 0.8735
No 0.81 [0.63–1.04] 1.62 [1.26–2.08] 1.07 [0.78–1.47] 0.97 [0.68–1.38]
How frequently do you see a healthcare provider?
4 + times per year ref ref <0.0001 ref ref 0.2634
2–3 times per year 0.99 [0.81–1.21] 0.99 [0.78–1.26] 1.08 [0.85–1.36] 0.81 [0.59–1.10]
1 time per year 1.02 [0.79–1.31] 1.71 [1.28–2.28] 1.07 [0.79–1.46] 0.88 [0.60–1.28]
< 1 time per year 1.05 [0.78–1.41] 3.58 [2.65–4.84] 1.48 [1.03–2.14] 1.01 [0.67–1.52]
How would you rate your general health?
Poor ref ref <0.0001 ref ref <0.0001
Fair 1.47 [0.94–2.3] 1.52 [0.9–2.59] 1.37 [0.77–2.43] 0.87 [0.42–1.81]
Good 1.31 [0.82–2.09] 1.09 [0.62–1.91] 1.42 [0.81–2.48] 1.20 [0.60–2.43]
Excellent 1.52 [0.94–2.46] 2.93 [1.68–5.1] 1.26 [0.69–2.29] 2.13 [1.02–4.46]
What is your marital status?
Married/living together ref ref 0.0006 ref ref 0.0341
Never married 1.11 [0.86–1.44] 0.66 [0.48–0.9] 1.11 [0.80–1.54] 0.56 [0.36–0.86]
Divorced or separated 0.86 [0.69–1.08] 0.75 [0.58–0.97] 1.16 [0.89–1.52] 0.81 [0.57–1.13]
Widowed 1.02 [0.75–1.39] 0.63 [0.43–0.92] 1.08 [0.75–1.58] 1.22 [0.74–2.03]
Annual household income
Less than $20,000 ref ref 0.0108 ref ref 0.1123
$20,000-$34,999 0.89 [0.62–1.29] 1 [0.66–1.51] 1.11 [0.69–1.77] 0.83 [0.46–1.47]
$35,000-$49,000 1.19 [0.82–1.72] 1.2 [0.79–1.81] 1.46 [0.90–2.37] 1.41 [0.78–2.54]
$50,000-$74,999 1.3 [0.92–1.82] 1.28 [0.88–1.86] 1.45 [0.90–2.34] 1.27 [0.70–2.28]
$75,000-$99,000 1.51 [1.07–2.14] 1.34 [0.9–1.97] 1.47 [0.88–2.45] 1.83 [0.98–3.43]
$100,000 or more 1.57 [1.13–2.18] 1.25 [0.86–1.81] 1.56 [0.93–2.61] 1.23 [0.65–2.33]
Employment status
Full-time employed/homemaker ref ref <0.0001 ref ref 0.0009
Part-time employed 1.23 [0.9–1.69] 0.96 [0.68–1.34] 1.45 [1.00–2.10] 1.14 [0.73–1.79]
Unemployed or disabled 1.15 [0.85–1.55] 0.94 [0.68–1.29] 1.51 [1.04–2.21] 1.08 [0.69–1.68]
Student 4.45 [1.98–9.99] 0.88 [0.31–2.53] 4.32 [1.62–11.49] 0.76 [0.19–3.13]
Retired 1.59 [1.34–1.9] 0.57 [0.46–0.71] 1.60 [1.19–2.16] 0.90 [0.62–1.32]
How would you describe your political views?
Liberal ref ref <0.0001 ref ref <0.0001
Moderate 0.47 [0.37–0.59] 3.13 [2.05–4.78] 0.48 [0.36–0.62] 3.30 [1.93–5.64]
Conservative 0.32 [0.26–0.4] 7.75 [5.22–11.52] 0.28 [0.21–0.37] 7.85 [4.64–13.29]
Have you had or do you plan to get the flu vaccine this year?
Yes ref ref <0.0001 ref ref <0.0001
No 0.17 [0.13–0.22] 12.01 [9.71–14.85] 0.19 [0.14–0.25] 9.07 [7.11–11.59]
Don't know/Not sure 0.32 [0.23–0.44] 1.54 [1.04–2.28] 0.34 [0.23–0.49] 1.29 [0.83–2.00]
How has the COVID-19 pandemic affected your likelihood of getting the flu vaccine this year?
Made me more likely to get it ref ref <0.0001 ref ref <0.0001
Has not affected my likelihood 0.52 [0.44–0.62] 7.35 [5.23–10.32] 0.59 [0.48–0.72] 2.60 [1.77–3.80]
Made me less likely to get it 0.22 [0.13–0.37] 26.85 [16.95–42.53] 0.42 [0.23–0.78] 4.70 [2.69–8.21]
Have you ever tested positive for COVID-19?
No ref ref 0.0741 ref ref 0.2868
Yes 0.76 [0.56–1.02] 1.03 [0.76–1.42] 0.76 [0.54–1.07] 0.91 [0.61–1.36]
Preventative measures composite score
Very frequently ref ref <0.0001 ref ref <0.0001
Somewhat frequently 1 [0.8–1.25] 0.92 [0.62–1.35] 1.03 [0.79–1.34] 1.01 [0.64–1.60]
Occasionally 0.93 [0.73–1.17] 1.47 [1.01–2.14] 0.81 [0.61–1.06] 1.91 [1.22–2.99]
Rarely 0.5 [0.39–0.63] 3.09 [2.22–4.31] 0.40 [0.30–0.53] 2.51 [1.65–3.81]
Never 0.26 [0.18–0.36] 16.29 [11.57–22.93] 0.22 [0.14–0.33] 12.67 [8.04–19.98]
Knowledge Questions:
It can take 214 days for coronavirus symptoms to appear in an infected person.
Agree ref ref <0.0001 ref ref <0.0001
Disagree 0.47 [0.26–0.86] 5.03 [3.22–7.84] 0.49 [0.24–1.00] 3.03 [1.65–5.60]
Individuals should quarantine after exposure to someone positive for COVID-19.
Agree ref ref <0.0001 ref ref <0.0001
Disagree 0.31 [0.22–0.43] 6.66 [5.24–8.47] 0.27 [0.18–0.40] 4.27 [3.10–5.88]
COVID-19 can live on surfaces, such as counters and doorknobs.
Agree ref ref <0.0001 ref ref <0.0001
Disagree 0.62 [0.48–0.8] 3.59 [2.86–4.51] 0.51 [0.37–0.69] 2.96 [2.19–4.00]
COVID-19 can cause lasting health issues even after recovery from the illness.
Agree ref ref <0.0001 ref ref <0.0001
Disagree 0.43 [0.3–0.62] 6.51 [4.93–8.6] 0.39 [0.25–0.60] 3.92 [2.72–5.65]
Wearing a face mask helps to prevent the spread of COVID-19.
Agree ref ref <0.0001 ref ref <0.0001
Disagree 0.26 [0.2–0.34] 10.39 [8.44–12.8] 0.25 [0.18–0.35] 6.79 [5.11–9.01]
People infected with COVID-19 who do not have the symptoms cannot spread the virus.
Agree ref ref <0.0001 ref ref <0.0001
Disagree 1.04 [0.8–1.34] 0.3 [0.24–0.38] 1.2 [0.90–1.61] 0.38 [0.28–0.53]
Most people with COVID-19 will have severe or critical symptoms.
Agree ref ref 0.0068 ref ref 0.2234
Disagree 1.48 [1.11–1.97] 1.6 [1.15–2.24] 1.25 [0.89–1.77] 1.40 [0.91–2.17]
COVID-19 can spread through respiratory droplets of infected people.
Agree ref ref <0.0001 ref ref <0.0001
Disagree 0.63 [0.27–1.45] 13.52 [7.25–25.22] 0.37 [0.14–0.99] 8.91 [4.29–18.51]
Underlying medical conditions increase your risk for developing a severe case of COVID-19.
Agree ref ref <0.0001 ref ref <0.0001
Disagree 0.4 [0.23–0.7] 4.12 [2.74–6.19] 0.38 [0.20–0.72] 4.27 [2.49–7.31]
People with COVID-19 can infect others days before they start having symptoms.
Agree ref ref <0.0001 ref ref <0.0001
Disagree 0.3 [0.2–0.45] 5.88 [4.47–7.74] 0.23 [0.14–0.37] 3.60 [2.54–5.11]
If you are wearing a mask it is not necessary to social distance.
Agree ref ref <0.0001 ref ref <0.0001
Disagree 2.46 [1.81–3.33] 0.2 [0.16–0.26] 2.94 [2.05–4.21] 0.34 [0.25–0.47]
Knowledge composite score
11 ref ref <0.0001 ref ref <0.0001
>8–10 0.66 [0.56–0.79] 2.75 [2.19–3.45] 0.65 [0.53–0.79] 2.09 [1.58–2.77]
>6–8 0.31 [0.21–0.15] 9.04 [6.67–12.26] 0.28 [0.18–0.42] 5.80 [3.93–8.57]
0–6 0.19 [0.10–0.35] 21.99 [15.01–32.21] 0.10 [0.05–0.23] 14.26 [8.66–23.48]
Belief statements:
COVID-19 is deadlier than seasonal flu.
Strongly Agree ref ref <0.0001 ref ref <0.0001
Agree 0.65 [0.54–0.79] 1.81 [1.32–2.49] 0.64 [0.51–0.80] 1.59 [1.08–2.33]
Neutral 0.25 [0.2–0.32] 3.4 [2.53–4.58] 0.26 [0.19–0.34] 2.61 [1.80–3.79]
Disagree 0.33 [0.25–0.43] 10.68 [7.89–14.45] 0.31 [0.22–0.43] 7.04 [4.79–10.35]
Strongly Disagree 0.25 [0.15–0.41] 33.11 [22.37–49] 0.20 [0.11–0.36] 19.44 [11.82–31.98]
I am worried about spreading COVID-19 to others.
Strongly Agree ref ref <0.0001 ref ref <0.0001
Agree 0.67 [0.54–0.81] 1.24 [0.88–1.76] 0.60 [0.47–0.75] 1.45 [0.96–2.20]
Neutral 0.31 [0.24–0.4] 3.06 [2.17–4.32] 0.28 [0.21–0.38] 2.56 [1.67–3.92]
Disagree 0.31 [0.24–0.41] 6.66 [4.76–9.33] 0.27 [0.19–0.37] 5.18 [3.39–7.91]
Strongly Disagree 0.34 [0.23–0.5] 18.77 [12.66–27.85] 0.26 [0.16–0.41] 12.71 [7.78–20.76]
COVID-91 is a serious disease.
Strongly Agree ref ref <0.0001 ref ref <0.0001
Agree 0.5 [0.42–0.6] 3.29 [2.57–4.21] 0.52 [0.42–0.64] 3.05 [2.23–4.16]
Neutral 0.25 [0.18–0.36] 10.1 [7.52–13.58] 0.22 [0.15–0.33] 7.90 [5.37–11.62]
Disagree 0.28 [0.17–0.46] 18.17 [12.48–26.45] 0.26 [0.15–0.46] 10.35 [6.39–16.76]
Strongly Disagree 0.49 [0.25–0.96] 42.48 [24.98–72.25] 0.36 [0.17–0.76] 19.50 [10.48–36.29]
People do not take COVID-19 seriously enough.
Strongly Agree ref ref <0.0001 ref ref <0.0001
Agree 0.69 [0.57–0.84] 1.3 [0.96–1.75] 0.63 [0.50–0.79] 1.32 [0.91–1.92]
Neutral 0.29 [0.22–0.37] 3.82 [2.9–5.04] 0.24 [0.17–0.32] 3.11 [2.17–4.45]
Disagree 0.3 [0.23–0.4] 7.35 [5.56–9.72] 0.26 [0.18–0.37] 5.82 [4.00–8.48]
Strongly Disagree 0.4 [0.25–0.63] 23.23 [15.9–33.93] 0.36 [0.21–0.63] 13.11 [8.08–21.25]
I am worried about getting COVID-19.
Strongly Agree ref ref <0.0001 ref ref <0.0001
Agree 0.77 [0.62–0.95] 0.83 [0.58–1.2] 0.62 [0.48–0.80] 0.85 [0.55–1.31]
Neutral 0.48 [0.38–0.6] 1.8 [1.27–2.54] 0.40 [0.30–0.53] 1.54 [1.01–2.37]
Disagree 0.29 [0.23–0.38] 4.17 [2.99–5.81] 0.25 [0.18–0.35] 3.84 [2.51–5.87]
Strongly Disagree 0.32 [0.22–0.48] 21.18 [14.47–30.99] 0.25 [0.16–0.41] 11.92 [7.34–19.34]
COVID-19 is a political issue.
Strongly Agree ref ref <0.0001 ref ref <0.0001
Agree 1.1 [0.85–1.4] 0.37 [0.29–0.47] 1.18 [0.88–1.59] 0.41 [0.30–0.56]
Neutral 0.75 [0.57–0.99] 0.2 [0.15–0.27] 0.81 [0.58–1.13] 0.25 [0.17–0.37]
Disagree 1.24 [0.95–1.62] 0.14 [0.1–0.19] 1.48 [1.07–2.04] 0.20 [0.13–0.31]
Strongly Disagree 1.93 [1.53–2.43] 0.09 [0.07–0.12] 2.08 [1.56–2.78] 0.14 [0.09–0.21]
  • a.

    Adjusted for age, rural vs urban, gender, race, education, insurance, rating of general health, marital status, employment status, 2020–21 flu vaccine receipt/intent, and prior positive COVID-19 diagnosis.

  • b.

    Includes American Indian or Alaska Native, Asian, more than one race, or “other”

Attitudes towards COVID-19 vaccination were highly correlated with attitudes towards the influenza vaccine. Respondents who said “No” to COVID-19 vaccine intention were over 9 times more likely to say “No” to having received or planning to receive an influenza vaccine this season (AOR: 9.07, 95% CI: 7.11–11.59) and almost 5 times more likely to say that the COVID-19 pandemic made them less likely to receive an influenza vaccine this year (AOR: 4.7, 95% CI: 2.69–8.21). Additionally, there was a high association with strong disagreement to the statement “COVID-19 is deadlier than the flu” (AOR: 19.44, 95% CI: 11.82–31.98). The opposite trends were observed for respondents who said “Yes” to COVID-19 vaccine intention.

Failure to engage in preventive behaviors was strongly associated with “No” responses (AOR: 12.67, 95% CI: 8.04–19.98) and negatively associated with “Yes” responses (AOR: 0.22, 95% CI: 0.14–0.33). A low knowledge composite score was also strongly associated with “No” responses (0–6 versus 11; AOR: 14.26, 95% CI: 8.66–23.48) and negatively associated with “Yes” responses (AOR: 0.10, 95% CI: 0.05–0.23). Specific knowledge questions demonstrating the highest association with “No” versus “Don’t know/Not sure” included disagreeing with the statements “individuals should quarantine after exposure to someone with COVID-19” (AOR: 4.27, 95% CI: 3.10–5.88), “COVID-19 can live on surfaces such as counters and doorknobs” (AOR: 2.96, 95% CI: 2.19–4.00), “COVID-19 can cause lasting health issues even after recovery from the illness” (AOR: 3.92, 95% CI: 2.72–5.65), and “people with COVID-19 can infect others days before they start having symptoms” (AOR: 3.60, 95% CI: 2.54–5.11). Of those who responded “No” to vaccination intention, 70.4% (N = 707) disagreed that wearing a face mask helps to prevent the spread of COVID-19 (AOR: 6.79, 95% CI: 5.11–9.01).

Participants who replied “No” to COVID-19 vaccination intent were also more likely to strongly disagree with several statements about beliefs surrounding COVID-19, including “I am worried about spreading COVID-19 to others” (AOR: 12.71, 95% CI: 7.78–10.76), “COVID-19 is a serious disease” (AOR: 19.5, 95% CI: 10.48–36.29), “People do not take COVID-19 seriously enough” (AOR: 13.11, 95% CI: 8.08–21.25), and “I am worried about getting COVID-19” (AOR: 11.92, 95% CI: 7.34–19.34). Participants who replied “Yes” were more likely to strongly disagree that COVID-19 is a political issue (AOR: 2.08, 95% CI: 1.56–2.78).

4. Discussion

The current study focused on factors associated with COVID-19 vaccine intentions in a population of adult Alabama residents using an online, social media-based survey. The goal of this study was to identify these factors to facilitate development of targeted behavioral and clinical interventions to reduce vaccine hesitancy and increase uptake. Notable findings included the association between conservative political viewpoints, and lower COVID-19 knowledge level with less intention to vaccinate, as well as the association between intention to receive the influenza vaccine with intention to receive a COVID-19 vaccine.

>1 in 4 of the respondents did not believe that COVID-19 was deadlier than influenza. Further, over half of those stated they would not receive a COVID-19 vaccine. Paradoxically, over 5% of all respondents stated the pandemic made them less likely to get an influenza vaccine. This seemingly contradictory finding could be due to the politicized nature of the coronavirus pandemic; approximately half of respondents in this study reported a belief that COVID-19 is a political issue—consistent with other surveys [28], [29]. Inconsistent messaging regarding COVID-19 infections and vaccines from the those in positions of power may have discouraged trust in vaccination. Self-reported conservatives were more likely than individuals identifying with other political views to report no intention to receive a COVID-19 vaccine, a finding which may reflect the timing of this survey but is in conflict with other surveys which indicate that belief in authority correlates with intent to receive the influenza vaccination [30]. Polarization across party lines has been seen with some influenza vaccine campaigns, with liberals more willing to be vaccinated than conservatives during the most recent swine flu scare and in current Kaiser Family Foundation Polls [31], [32]. Our findings suggest that, in Alabama, political party identification is more important than trust in the government when estimating vaccination intent. To avoid this same issue in the future, public health messaging by the media and government officials should avoid fueling potentially damaging and dangerous attitudes. Regarding the current pandemic, our data suggest that individuals with conservative or moderate viewpoints may be in greatest need of targeting for pro-vaccine education to increase uptake; in the current sample, these groups expressed the greatest indecision toward receiving a COVID-19 vaccine.

Low COVID-19 knowledge levels were strongly associated with no intention to vaccinate, consistent with previous studies [33], [34], [35]. In addition, those with the lowest summary scores of the knowledge questions were more likely to say “No” to vaccine intent after adjusting for educational level. Misbeliefs about COVID-19 severity were also strongly correlated with intention to vaccinate. Disagreeing with the following phrases: “COVID-19 is a serious disease,” “I am worried about spreading COVID-19 to others,” “I am worried about getting COVID-19,” and, “People do not take COVID-19 seriously enough,” were all highly associated with no intention to receive a COVID-19 vaccine. This is consistent with other surveys which have demonstrated that participants without concern about the severity of the disease do not view the vaccine as a priority [36], [37]. Our study also found higher educational attainment to be an important influencer of vaccination intent, consistent with the literature [38]. The interaction between knowledge level and education level and their influence on vaccine intentions for COVID-19 specifically have not been thoroughly explored [39]. Previous studies have demonstrated an association between low income and lack of intention to vaccinate, which may provide some explanation as income is strongly related to education level [34], [38], [40]. These results demonstrate the need for improved education about COVID-19, including the mechanisms of spread and sequelae, and implicate the need for targeted messaging to low-income populations in order to improve vaccine uptake.

The racial association of lower intention to vaccinate among African American participants reported here is also supported by previous work [35], [36], [41], [42]. This is likely due in part to income and educational attainment disparities among African Americans compared to Whites [43]. However, the history of mistreatment at the hands of the medical community of this population, especially in Alabama, cannot be ignored [44], [45], [46], [47]. Mistrust has already been documented relative to COVID-19 severity and vaccination in this population [48]. Lower intention to vaccinate and already lower uptake by African Americans could exacerbate the already present COVID-19 disparities in this population [44], [49], [50]. Our results underscore the need for targeted messaging and access for this population.

A high correlation was found between intention to receive an influenza vaccine and intention to receive a COVID-19 vaccine. The exploration of this relationship highlights attitudes that could be used both to reduce vaccine hesitancy as well as assist in identifying the best locations for COVID-19 vaccine distribution. Three of the top five reported reasons given to get the influenza vaccine included healthcare provider (HCP) recommendation; not wanting to give the illness to others; to lessen the severity of influenza should an individual get it. Strong HCP recommendations for vaccine receipt is a well-known positive driver of increased vaccine uptake, and these recommendations should be emphasized to increase COVID-19 vaccine uptake as well [51]. The desire to be protected from giving influenza to others illustrates a civic duty among this sample of Alabama residents that could be stressed by both the media and healthcare workers to increase receipt of the COVID-19 vaccine [52]. Approximately 4 out of 10 respondents stated that they receive an influenza vaccine in order to lessen the severity of the disease if they get it, offering another opportunity for messaging. The use of incentives is controversial with only larger incentives (i.e. $100 or more) being shown to increase general vaccine uptake [21]. Money may be better spent on targeted messaging.

The places survey respondents most reported getting an influenza vaccine were at a healthcare provider’s office or clinic (42%) and at a pharmacy (up to 59%). These results were the same as locations noted for where participants stated they would be most likely to receive a COVID-19 vaccine, for reasons of convenience and ease of access [53]. The desire to recreate this for the COVID-19 vaccination efforts may be due to an increased comfort level in a familiar clinic or pharmacy coupled with the discomfort of the novel activity of receiving an injection in a car. Only 19% of respondents stated they would be most likely to get a COVID-19 vaccine at a drive-through site. Increasing vaccine availability in these familiar sites could increase uptake in hard-to-reach populations. Those who are unsure about receiving a COVID-19 vaccine may be more inclined to get it from the relative comfort of a trusted healthcare provider or pharmacist.

Concern about side effects and ingredients of the influenza vaccines were two of the top five reasons to not receive an influenza vaccine annually (16.6% and 17.0% respectively). Perceived safety of a vaccine has proven to be an indicator of uptake, and both side effects and ingredients of a vaccine can influence an individual’s perception of that vaccine’s safety [54], [55]. The COVID-19 vaccines, especially the second shot of the Pfizer vaccine, are known for relatively severe side effects, especially fever, chills, muscle aches, and fatigue. Concern about vaccine side effects and ingredients could affect uptake of a particularly novel and comparatively “rushed” COVID-19 vaccine, even though it has passed all safety protocols. HCP reassurance for the safety and rigorous testing of the COVID-19 vaccines could help alleviate some of these concerns.

Limitations to this study included low response rates for African American race and male sex, possibly leading to an overestimation of willingness to be vaccinated. The relatively high levels of missing data (>5%) for income, political views, and age may have also affected the outcomes. To mitigate the effect of missing data on the analyses, income and political views were not included in the adjusted regression model. It is likely that any bias due to remaining missing values was negligible [56]. Additionally, this study had a much higher percentage (60.5%) of participants who identified as having a college degree than the Alabama population (25%) [56]. This could be due to the survey medium, as a higher portion of adults with a college degree (74%) use Facebook compared with those with a high school diploma or less (61%) [54]. However, it is likely that any bias due to under-representation of populations with lower educational attainment was towards the null among those who responded “No” to vaccination intent [55], [56]. The time frame the survey was open may also have affected the results. Election confusion, vaccine rollouts, and other major events occurred simultaneous with the survey. Due to these events occurring in close proximity some answers may have reflected more polarizing attitudes on certain topics than would have otherwise been documented. Finally, due to the rapid onset of the pandemic, no fully validated instruments specifically assessing COVID-19 vaccination had been developed at the time of the current study, though validated measures were used whenever possible.

5. Conclusion

Ensuring adequate COVID-19 vaccination in the U.S. is and will likely continue to be challenging. Individual attitudes and perceptions are extremely influential on uptake. Previous research has identified populations most likely to refuse the vaccine and thus requiring the most intervention to improve uptake. Our research confirms these findings are also accurate in the state of Alabama, while also adding avenues to increase COVID-19 vaccine uptake through analysis of influenza vaccine attitudes. Future research should explore the efficacy of vaccine education and uptake programs among populations identified to be hesitant toward the COVID-19 vaccines. Additionally, strategies to persuade those who are undecided should be studied as this is a major segment of the population and vaccinating them is essential to reaching herd immunity and ending the pandemic.

Funding

Funding for the current study was provided by the Immunization Division of the Alabama Department of Public Health (Study PI: Daniel, CL) from funds designated by the Centers for Disease Control and Prevention (CDC-RFA-IP19-1901).

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  • 1.CDC. About COVID-19. Centers for Disease Control and Prevention. Accessed March 23, 2021, 2021. https://www.cdc.gov/coronavirus/2019-ncov/cdcresponse/about-COVID-19.html
  • 2.Harcourt J, Tamin A, Lu X, et al. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States. Emerg Infect Dis. Jun 2020;26(6):1266-1273. doi:10.3201/eid2606.200516 [DOI] [PMC free article] [PubMed]
  • 3.CDC. United States COVID-19 Cases and Deaths by State. Centers for Disease Control and Prevention. Accessed March 25, 2021, 2021. https://covid.cdc.gov/covid-data-tracker/#cases_casesper100klast7days
  • 4.ADPH. Alabama's COVID-19 Data and Surveillance Dashboard 2021. Alabama Department of Public Health. Accessed March 25, 2021, 2021. https://alpublichealth.maps.arcgis.com/apps/opsdashboard/index.html#/6d2771faa9da4a2786a509d82c8cf0f7
  • 5.CDC. How COVID-19 Spreads. Centers for Disease Control and Prevention. Accessed March 23, 2021, 2021. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html
  • 6.Morawska L., Cao J. Airborne transmission of SARS-CoV-2: The world should face the reality. Environ Int. 2020;139:105730. doi: 10.1016/j.envint.2020.105730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Milovanovic L., Hessey E., Sebastianski M., Keto-Lambert D., Vandermeer B., Bagshaw S.M., et al. Epidemiology, clinical characteristics and treatment of critically ill patients with COVID-19): a protocol for a living systematic review. BMJ Open. 2021;11(1):e042008. doi: 10.1136/bmjopen-2020-042008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Basu A. Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United States. Health Aff (Millwood) Jul 2020;39(7):1229–1236. doi: 10.1377/hlthaff.2020.00455. [DOI] [PubMed] [Google Scholar]
  • 9.WHO. What we know about long-term effects of COVID-19. Accessed March 23, 2021, 2021. https://www.who.int/docs/default-source/coronaviruse/risk-comms-updates/update-36-long-term-symptoms.pdf?sfvrsn=5d3789a6_2#:∼:text=%E2%80%A2%20Most%20people%20with%20COVID,have%20lasting%20health%20effects
  • 10.Xiong W, Kwan P, Zhou D, Del Felice A, Duncan JS, Sander JW. Acute and late neurological complications of COVID19: the quest for evidence. Brain. Dec 1 2020;143(12):e99. doi:10.1093/brain/awaa294 [DOI] [PMC free article] [PubMed]
  • 11.CDC. Science Brief: Community use of cloth masks to control the spread of SARS-CoV-2. Accessed March 23, 2021, 2021. https://www.cdc.gov/coronavirus/2019-ncov/more/masking-science-sars-cov2.html
  • 12.Matrajt L, Leung T. Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease. Emerg Infect Dis. Aug 2020;26(8):1740-1748. doi:10.3201/eid2608.201093 [DOI] [PMC free article] [PubMed]
  • 13.Kwok K.O., Lai F., Wei W.I., Wong S.Y.S., Tang J.W.T. Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries. J Infect. 2020;80(6):e32–e33. doi: 10.1016/j.jinf.2020.03.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.McClure C.C., Cataldi J.R., O'Leary S.T. Vaccine Hesitancy: Where We Are and Where We Are Going. Clin Ther. 2017;39(8):1550–1562. doi: 10.1016/j.clinthera.2017.07.003. [DOI] [PubMed] [Google Scholar]
  • 15.Dubé E., Gagnon D., Nickels E., Jeram S., Schuster M. Mapping vaccine hesitancy–country-specific characteristics of a global phenomenon. Vaccine. 2014;32(49):6649–6654. doi: 10.1016/j.vaccine.2014.09.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dubé E., Vivion M., MacDonald N.E. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vacc. Jan 2015;14(1):99–117. doi: 10.1586/14760584.2015.964212. [DOI] [PubMed] [Google Scholar]
  • 17.Larson H.J., Jarrett C., Eckersberger E., Smith D.M., Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–2159. doi: 10.1016/j.vaccine.2014.01.081. [DOI] [PubMed] [Google Scholar]
  • 18.Schmid P., Rauber D., Betsch C., Lidolt G., Denker M.-L., Cowling B.J. Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005–2016. PloS One. 2017;12(1):e0170550. doi: 10.1371/journal.pone.0170550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.CDC. COVID-19 Vaccinations in the United States. Accessed March 25, 2021, 2021. https://covid.cdc.gov/covid-data-tracker/#vaccinations
  • 20.NYT. See How the Vaccine Rollout is Going in Your Country and State. Accessed March 28, 2021, 2021. https://www.nytimes.com/interactive/2020/us/covid-19-vaccine-doses.html
  • 21.Lin C, Tu P, Beitsch LM. Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review. Vaccines (Basel). Dec 30 2020;9(1)doi:10.3390/vaccines9010016 [DOI] [PMC free article] [PubMed]
  • 22.Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. Apr 2009;42(2):377-81. doi:10.1016/j.jbi.2008.08.010 [DOI] [PMC free article] [PubMed]
  • 23.Shaver LG, Khawer A, Yi Y, et al. Using Facebook Advertising to Recruit Representative Samples: Feasibility Assessment of a Cross-Sectional Survey. J Med Internet Res. Aug 19 2019;21(8):e14021. doi:10.2196/14021 [DOI] [PMC free article] [PubMed]
  • 24.Ali S.H., Foreman J., Capasso A., Jones A.M., Tozan Y., DiClemente R.J. Social media as a recruitment platform for a nationwide online survey of COVID-19 knowledge, beliefs, and practices in the United States: methodology and feasibility analysis. BMC Med Res Methodol. 2020;20(1) doi: 10.1186/s12874-020-01011-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.USDA. Rural-Urban Commuting Area Codes. Accessed March 23, 2021, 2021. https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes.aspx#:∼:text=The%20rural%2Durban%20commuting%20area,%2C%20urbanization%2C%20and%20daily%20commuting.&text=Whole%20numbers%20(1%2D10),primary%20(largest)%20commuting%20flows
  • 26.Facebook. Audience Insights. Accessed March 20, 2021, 2021. https://www.facebook.com/business/insights/tools/audience-insights
  • 27.Topolovec-Vranic J, Natarajan K. The Use of Social Media in Recruitment for Medical Research Studies: A Scoping Review. J Med Internet Res. Nov 7 2016;18(11):e286. doi:10.2196/jmir.5698 [DOI] [PMC free article] [PubMed]
  • 28.Hornsey MJ, Finlayson M, Chatwood G, Begeny CT. The effect of political identity, conspiracist ideation and presidential tweets on vaccine hesitancy. Journal of Experimental Social Psychology. 2020:88
  • 29.Daly M., Robinson E. Willingness to Vaccinate Against COVID-19 in the U.S.: Representative Longitudinal Evidence From April to October 2020. Am J Prev Med. 2021;60(6):766–773. doi: 10.1016/j.amepre.2021.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Mesch GS, Schwirian KP. Confidence in government and vaccination willingness in the USA. Health Promot Int. Jun 2015;30(2):213-21. doi:10.1093/heapro/dau094 [DOI] [PubMed]
  • 31.Pogue K, Jensen JL, Stancil CK, et al. Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States. Vaccines (Basel). Oct 3 2020;8(4)doi:10.3390/vaccines8040582 [DOI] [PMC free article] [PubMed]
  • 32.Hamel L, Kirzinger A, Lopes L, et al. KFF COVID-19 Vaccine Monitor: May 2021. Kaiser Family Foundation. Accessed December 5, 2021, 2021. https://www.kff.org/coronavirus-covid-19/poll-finding/kff-covid-19-vaccine-monitor-may-2021/
  • 33.Thigpen CL, Funk C. Most Americans expect a COVID-19 vaccine within a year; 72% say they would get vaccinated. Accessed March 20, 2021, 2021. https://www.pewresearch.org/fact-tank/2020/05/21/most-americans-expect-a-covid-19-vaccine-within-a-year-72-say-they-would-get-vaccinated/
  • 34.Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine. Sep 29 2020;38(42):6500-6507. doi:10.1016/j.vaccine.2020.08.043 [DOI] [PMC free article] [PubMed]
  • 35.Smyton R, McAndrew J. Only 57 percent of Americans say they would get a COVID-19 vaccine. Accessed March 20, 2021, 2021. https://now.tufts.edu/news-releases/only-57-percent-americans-say-they-would-get-covid-19-vaccine
  • 36.Wong L.P., Alias H., Wong P.F., Lee H.Y., AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Human Vacc Immunotherapeut. 2020;16(9):2204–2214. doi: 10.1080/21645515.2020.1790279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Khubchandani J., Sharma S., Price J.H., Wiblishauser M.J., Sharma M., Webb F.J. COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment. J Community Health. 2021;46(2):270–277. doi: 10.1007/s10900-020-00958-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Demographic trends and economic well-being. Accessed March 21, 2021, 2021. https://www.pewresearch.org/social-trends/2016/06/27/1-demographic-trends-and-economic-well-being/
  • 39.Robinson E., Jones A., Lesser I., Daly M. International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples. Vaccine. 2021;39(15):2024–2034. doi: 10.1016/j.vaccine.2021.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Fisher K.A., Bloomstone S.J., Walder J., Crawford S., Fouayzi H., Mazor K.M. Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S Adults. Ann Intern Med. 2020;173(12):964–973. doi: 10.7326/m20-3569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Adams L.B., Richmond J., Corbie-Smith G., Powell W. Medical Mistrust and Colorectal Cancer Screening Among African Americans. J Community Health. Oct 2017;42(5):1044–1061. doi: 10.1007/s10900-017-0339-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Powell W., Richmond J., Mohottige D., Yen I., Joslyn A., Corbie-Smith G. Medical Mistrust, Racism, and Delays in Preventive Health Screening Among African-American Men. Behav Med. 2019;45(2):102–117. doi: 10.1080/08964289.2019.1585327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kolar S.K., Wheldon C., Hernandez N.D., Young L., Romero-Daza N., Daley E.M. Human Papillomavirus Vaccine Knowledge and Attitudes, Preventative Health Behaviors, and Medical Mistrust Among a Racially and Ethnically Diverse Sample of College Women. J Racial Ethn Health Disparities. Mar 2015;2(1):77–85. doi: 10.1007/s40615-014-0050-2. [DOI] [PubMed] [Google Scholar]
  • 44.Bogart L.M., Ojikutu B.O., Tyagi K., Klein D.J., Mutchler M.G., Dong L.u., et al. COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV. J Acquir Immune Defic Syndr. 2021;86(2):200–207. doi: 10.1097/QAI.0000000000002570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Walker AS, Singhvi A, Holder J, Gebeloff R, Avila Y. Pandemic's Racial Disparities Persist in Vaccine Rollout. Accessed March 21, 2021, https://www.nytimes.com/interactive/2021/03/05/us/vaccine-racial-disparities.html?action=click&module=Top%20Stories&pgtype=Homepage
  • 46.Kullar R., Marcelin J.R., Swartz T.H., Piggott D.A., Macias Gil R., Mathew T.A., et al. Racial Disparity of Coronavirus Disease 2019 in African American Communities. J Infect Dis. 2020;222(6):890–893. doi: 10.1093/infdis/jiaa372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Paterson P., Meurice F., Stanberry L.R., Glismann S., Rosenthal S.L., Larson H.J. Vaccine hesitancy and healthcare providers. Vaccine. 2016;34(52):6700–6706. doi: 10.1016/j.vaccine.2016.10.042. [DOI] [PubMed] [Google Scholar]
  • 48.CDC. Similarities and Differences between Flu and COVID-19. Accessed March 21, 2021, https://www.cdc.gov/flu/symptoms/flu-vs-covid19.htm#:∼:text=COVID%2D19%20seems%20to%20spread,in%20the%20different%20sections%20below
  • 49.Gupta A., Evans G.W., Heragu S.S. Simulation and optimization modeling for drive-through mass vaccination–A generalized approach. Simul Model Pract Theory. 2013;37:99–106. [Google Scholar]
  • 50.Galarce E.M., Minsky S., Viswanath K. Socioeconomic status, demographics, beliefs and A(H1N1) vaccine uptake in the United States. Vaccine. 2011;29(32):5284–5289. doi: 10.1016/j.vaccine.2011.05.014. [DOI] [PubMed] [Google Scholar]
  • 51.Kennedy A., Lavail K., Nowak G., Basket M., Landry S. Confidence about vaccines in the United States: understanding parents' perceptions. Health Aff (Millwood) 2011;30(6):1151–1159. doi: 10.1377/hlthaff.2011.0396. [DOI] [PubMed] [Google Scholar]
  • 52.Jakobsen J.C., Gluud C., Wetterslev J., Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1) doi: 10.1186/s12874-017-0442-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Research ES. County-level Data Sets. Accessed March 20, 2021, https://www.ers.usda.gov/data-products/county-level-data-sets/
  • 54.Gramlich J. 10 facts about Americans and Facebook. Accessed March 21, 2021, https://www.pewresearch.org/fact-tank/2019/05/16/facts-about-americans-and-facebook/
  • 55.Paul E., Steptoe A., Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. LancetReg Health Eur. 2021;1:100012. doi: 10.1016/j.lanepe.2020.100012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Szilagyi P.G., Thomas K., Shah M.D., Vizueta N., Cui Y., Vangala S., et al. National Trends in the US Public's Likelihood of Getting a COVID-19 Vaccine. JAMA. 2020;325(4):396. doi: 10.1001/jama.2020.26419. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Vaccine are provided here courtesy of Elsevier

RESOURCES